NBIXNEUROCRINE BIOSCIENCES INCvs its industry peers
A metric-by-metric comparison of NEUROCRINE BIOSCIENCES INC against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIXEsta | $14.9B#6 | 21.4x#2 | 4.0x#2 | 5.2x#2 | 21.4%#1 | 40.2%#5 | 21.6%#6 | 13.0%#6 | — | — | 5.9%#7 | — |
| VRTX | $141.7B#3 | 32.6x#4 | 7.0x#3 | 11.8x#6 | 8.9%#3 | 838.1%#2 | 34.8%#1 | 19.5%#4 | 25.0%#2 | — | 33.1%#6 | — |
| AMGN | $252.0B#1 | 29.0x#3 | 21.6x#6 | 6.9x#3 | 10.0%#2 | 88.5%#4 | 24.7%#5 | 66.0%#1 | 15.1%#4 | — | 62.9%#3 | 2.0%#1 |
| GILD | $212.0B#2 | — | 16.3x#5 | 7.2x#4 | 2.4%#4 | 1672.9%#1 | 34.0%#2 | 65.3%#2 | 25.7%#1 | — | 47.1%#4 | 1.9%#2 |
| REGN | — | 20.5x#1 | — | — | 1.0%#6 | 2.1%#6 | 24.9%#4 | 13.4%#5 | 9.2%#6 | — | 41.7%#5 | — |
| BIIB | $37.5B#4 | 109.8x#6 | 2.5x#1 | 3.8x#1 | 2.2%#5 | -20.8%#7 | 28.7%#3 | 8.7%#7 | 12.3%#5 | 3#2 | 69.6%#2 | — |
| ILMN | $35.7B#5 | 40.6x#5 | 11.3x#4 | 8.2x#5 | -0.7%#7 | 169.5%#3 | 18.6%#7 | 27.0%#3 | 19.9%#3 | 8#1 | 138.0%#1 | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice